Bharat Biotech

Hyderabad: India's vaccine maker Bharat Biotech is collaborating with Washington University School of Medicine in St. Louis for a novel chimp-adenovirus, single-dose intranasal vaccine for…

New Delhi: A coronavirus vaccine will be available in the country by the beginning of next year, Union Health Minister Harsh Vardhan told the Rajya Sabha on Thursday. “Just like other…

New Delhi: Covaxin, the indigenously developed COVID-19 vaccine, has demonstrated protective efficacy and immunogenicity in non-human primates in Phase I clinical trials in India.…

New Delhi: Phase II trials of the indigenously developed COVID-19 vaccine, Covaxin, is likely to begin on Monday, according to a media report on Sunday. Covaxin has been developed by…

Hyderabad: The Drugs Controller General of India (DGCI) has given permission to Bharat Biotech to test its COVID-19 vaccine, COVAXIN, by administering it via the skin. This intradermal…

New Delhi: Covaxin, the indigenously developed COVID-19 vaccine, has been found to be safe, according to preliminary results of Phase-I clinical trials. Covaxin is developed by…

Hyderabad: The phase-2 clinical trial of the indigenously developed Covaxin began on Tuesday in Nagpur. Bharat Biotech, the Hyderabad-based firm behind it, is testing the vaccine at…

Hyderabad: Bharat Biotech International Limited (BBIL), which developed India’s first potential indigenous COVID-19 vaccine, has said that the first phase of testing has begun on 375…

New Delhi: Experts and medicos have criticised the Indian Council of Medical Research’s (ICMR) recent announcement that the indigenous COVID-19 vaccine, COVAXIN, will be available for public…

New Delhi: Bharat Biotech has disclaimed a social media image of the company’s vice president, Dr VK Srinivas, being injected with a COVID-19 vaccine. The company clarified that the image…